journal article·2023-12-31Open access

Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer

Chunjing Guo, Wei Zhang, Qiaoyun Zhang, Yanguo Su, Xiaoya Hou, Qiang Chen, Huimin Guo, Ming Kong, Daquan Chen

Abstract

Tumour development is not only an independent event of genetic mutation and overgrowth of tumour cells but is the result of a synergistic interaction between a malignant tumour and its surrounding tumour stromal microenvironment. In this paper, we address the shortcomings of current tumour therapy by focussing on the tumour itself and the surrounding microenvironment to achieve a two-pronged targeting model. In this paper, a dual-targeting, pH/reactive oxygen species (ROS) sensitive nano-drug delivery system for tumour cells and CAFs was designed. A hyaluronic acid (HA) with CD44 receptor targeting on the surface of tumour cells was selected as the main carrier material, and a dipeptide Z-glycine-proline (ZGP) with specific targeting of fibroblast activating protein (FAP) on the surface of CAFs was modified on HA to achieve precise targeting of CAFs, open the physical barrier of tumour cells and improve the deep penetration effect of the tumour, while introducing thioketone bond and ketone condensation bond to take advantage of the highly reactive ROS and low pH microenvironment at the tumour site to achieve chemical bond breaking of nano micelles encapsulating paclitaxel (PTX), drug release, and thus drug aggregation at the tumour site and improved bioavailability of the drug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Marine Life Science, Ocean University of China, Qingdao, PR China

Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai, PR China

Department of Radiotherapy, Yantai Yuhuangding Hospital, The Affiliated Hospital of Qingdao University, Yantai, PR China

Department of Clinical Laboratory, Penglai Traditional Chinese Medicine Hospital, Yantai, PR China

Funding

Taishan Scholar Foundation of Shandong Province · Natural Science Foundation of Shandong Province · Graduate Innovation Foundation of Yantai University, GIFYTU

References (27)

Show source-provided references
1. 10.1111/hepr.1318110.1111/hepr.13181 ↗
2. 10.1177/155798831879827910.1177/1557988318798279 ↗
3. 10.3389/fphar.2018.0123010.3389/fphar.2018.01230 ↗
4. 10.1038/s41573-018-0004-110.1038/s41573-018-0004-1 ↗
5. 10.1136/gutjnl-2012-30252910.1136/gutjnl-2012-302529 ↗
6. Wong KM · Current Oncology Reports · 2017 · 19 · 110.1007/s11912-017-0564-y ↗
7. 10.1016/j.addr.2015.07.00710.1016/j.addr.2015.07.007 ↗
8. 10.1172/JCI3898810.1172/JCI38988 ↗
9. 10.18632/oncotarget.362210.18632/oncotarget.3622 ↗
10. 10.1007/s12026-009-8119-410.1007/s12026-009-8119-4 ↗
11. 10.1002/ijc.2983110.1002/ijc.29831 ↗
12. 10.1002/ange.20150626210.1002/ange.201506262 ↗
13. 10.1016/j.canlet.2019.01.03210.1016/j.canlet.2019.01.032 ↗
14. 10.1016/j.jconrel.2016.09.01410.1016/j.jconrel.2016.09.014 ↗
15. 10.1016/j.ejphar.2017.09.01610.1016/j.ejphar.2017.09.016 ↗
16. 10.1016/j.cis.2020.10225110.1016/j.cis.2020.102251 ↗
17. Naveen C, Shastri N R. Polysaccharide nanomicelles as drug carriers[M]//Polysaccharide Carriers for Drug Delivery. Woodhead Publishing, 2019: 339–363.10.1016/B978-0-08-102553-6.00012-X ↗
18. Zheng Y · Int J Biol Macromol · 2020 · 165 · 266810.1016/j.ijbiomac.2020.10.173 ↗
19. 10.1039/C9BM01927H10.1039/C9BM01927H ↗
20. 10.1007/s42765-019-00012-z10.1007/s42765-019-00012-z ↗
21. Clement J, Rae A. Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders: U.S. Patent Application 11/753,900[P]. 2007-11-29.
22. 10.1016/j.phymed.2020.15335610.1016/j.phymed.2020.153356 ↗
23. 10.1002/mnfr.20200111810.1002/mnfr.202001118 ↗
24. 10.3109/10717544.2014.91713010.3109/10717544.2014.917130 ↗
25. 10.1021/acs.molpharmaceut.9b0008310.1021/acs.molpharmaceut.9b00083 ↗
26. Bousoik E · Sci Rep · 2020 · 10 · 110.1038/s41598-020-62727-z ↗
27. Thorne RF · Histochem Cell Biol · 2020 · 153 · 7710.1007/s00418-019-01835-y ↗